MSH Capital Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$370K Sell
4,735
-10,535
-69% -$850K 0.06% 237
2026
Q1
$1.32M Buy
15,270
+113
+0.7% +$10.8K 0.28% 90
2025
Q4
$1.46M Buy
15,157
+130
+0.9% +$12.6K 0.31% 88
2025
Q3
$1.43M Hold
15,027
0.38% 74
2025
Q2
$1.31M Buy
15,027
+518
+4% +$43.9K 0.38% 74
2025
Q1
$1.3M Buy
14,509
+182
+1% +$16.3K 0.4% 71
2024
Q4
$1.14M Sell
14,327
-472
-3% -$40.9K 0.36% 74
2024
Q3
$1.33M Buy
14,799
+235
+2% +$19.8K 0.41% 74
2024
Q2
$1.15M Buy
14,564
+1,179
+9% +$96.7K 0.38% 76
2024
Q1
$1.17M Buy
13,385
+425
+3% +$36.3K 0.41% 76
2023
Q4
$1.07M Sell
12,960
-653
-5% -$49.8K 0.4% 73
2023
Q3
$1.07M Buy
13,613
+451
+3% +$37.8K 0.42% 73
2023
Q2
$1.16M Buy
13,162
+77
+0.6% +$6.63K 0.42% 74
2023
Q1
$1.05M Buy
13,085
+238
+2% +$19.4K 0.45% 75
2022
Q4
$998K Sell
12,847
-661
-5% -$53.6K 0.45% 73
2022
Q3
$1.09M Buy
13,508
+150
+1% +$13.5K 0.54% 70
2022
Q2
$1.2M Buy
13,358
+3,281
+33% +$332K 0.56% 63
2022
Q1
$1.12M Buy
10,077
+1,260
+14% +$133K 0.46% 72
2021
Q4
$912K Buy
+8,817
New +$1.02M 0.41% 78

Other funds holding MDT

MSH Capital Advisors's MDT Position: Q2 2026 in Review

MSH Capital Advisors reduced its Medtronic (MDT) stake by 69% in Q2 2026, selling an estimated $850K and leaving 4,735 shares worth $370K. The position accounts for 0.06% of the portfolio, ranked #237.

MSH Capital Advisors first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.46M in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • MSH Capital Advisors held 4,735 shares of Medtronic worth $370K as of Q2 2026.
  • MSH Capital Advisors sold 10,535 Medtronic shares in Q2 2026, an estimated $850K.
  • Medtronic made up 0.06% of MSH Capital Advisors's portfolio in Q2 2026, its #237 holding.
  • MSH Capital Advisors first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
  • MSH Capital Advisors's Medtronic position peaked at $1.46M in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on MSH Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.